Extracellular Matrix Features Discriminate Aggressive HER2-Positive Breast Cancer Patients Who Benefit from Trastuzumab Treatment

We previously identified an extracellular matrix (ECM) gene expression pattern in breast cancer (BC), called ECM3, characterized by a high expression of genes encoding structural ECM proteins. Since ECM is reportedly implicated in response to therapy of BCs, the aim of this work is to investigate th...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cells
Hlavní autoři: Rybinska, Ilona, Sandri, Marco, Bianchi, Francesca, Orlandi, Rosaria, De Cecco, Loris, Gasparini, Patrizia, Campiglio, Manuela, Paolini, Biagio, Sfondrini, Lucia, Tagliabue, Elda, Triulzi, Tiziana
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2020
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7072535/
https://ncbi.nlm.nih.gov/pubmed/32069815
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells9020434
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky